Association of Early Myocardial Injury With Major Adverse Outcomes in Patients With COVID-19
Status: Completed
Location: See location...
Study Type: Observational
SUMMARY
The study will analyze the incidence, clinical outcomes and predictors of myocardial injury in a large patient population with COVID-19 treated in Mount Sinai Hospital (MSH) system. In addition, the study team will explore the association between high-sensitivity troponin I (TnI) levels and clinical characteristics, biomarkers, cardiac tests data and treatment approaches to uncover the potential mechanisms responsible for COVID-19 induced myocardial injury.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Laboratory confirmed COVID-19
Locations
United States
New York
Mount Sinai Hospital
New York
Time Frame
Start Date: 2020-05-08
Completion Date: 2022-03-01
Participants
Target number of participants: 4695
Treatments
Patients with Acute Cardiac Injury
Patients with acute cardiac injury
Patients without cardiac injury
Patients without cardiac injury
Patients with Chronic Cardiac Injury
Patients with chronic cardiac injury
Authors
Related Therapeutic Areas
Sponsors
Leads: Icahn School of Medicine at Mount Sinai